
63rd ERA Congress 2026
π― Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 63rd ERA Congress 2026 β the bestβfit companies to target, the exact decisionβmaker job titles, and the industry filters that fit what you sell.
About this event
ERA Congress 2026
Event type: Nephrology, renal medicine, dialysis, transplantation, CKD management, hospital care, clinical research, medical devices, pharmaceuticals, diagnostics, education, and scientific congress
Likely audience profile: Medical specialists, hospital decision-makers, researchers, healthcare educators, clinical procurement teams, dialysis providers, pharma and device companies, lab and diagnostic suppliers, and academic institutions
Estimated attendance: Typically a very large international medical congress format, often drawing several thousand professionals; final attendance should be verified from the official event organizer because medical congress numbers can vary by year and city
1) Who attends: Buyers / Attendees
ERA Congress 2026 is a high-value healthcare and clinical science event focused on kidney disease, renal care, dialysis, transplantation, and related therapeutic and diagnostic innovation. This is not a general consumer show. The strongest buyer value sits in the professional and institutional layer: doctors, researchers, hospital leaders, procurement teams, medical technology companies, pharma brands, and academic stakeholders.
The main attendee groups are usually:
- Nephrologists and renal specialists
- Hospital and clinic decision-makers
- Dialysis center managers and renal care providers
- Transplant surgeons and transplant program leaders
- Clinical researchers and trial investigators
- Pharmaceutical companies focused on renal, cardiovascular, metabolic, and chronic disease therapy
- Medical device manufacturers for dialysis, filtration, monitoring, imaging, and patient care
- Diagnostic and laboratory service providers
- Academic faculty, fellows, educators, and training institutions
- Healthcare policy, reimbursement, and patient advocacy professionals
For buyer-list building, the most valuable records are not only physicians. The most commercial contacts are usually:
- Medical Affairs Directors
- Clinical Research Managers
- Hospital Procurement Managers
- Director of Nephrology
- Dialysis Network Operations Leaders
- Product Managers for renal care devices
- Regional Sales Directors for pharma and medtech
- Research Program Leads in kidney disease, immunology, and internal medicine
2) Where the show is happening + attendee geographic origin
Show location: This should be confirmed from the official ERA Congress 2026 organizer page before final buyer targeting, because venue and city can change by year. Once the location is confirmed, attendee origin usually follows a strong international medical pattern.
Attendee geographic origin: ERA Congress is typically a pan-European and global medical congress, attracting participants from across Europe as well as the Middle East, North Africa, Asia, North America, and selected global healthcare markets. Kidney care is a worldwide specialty, so the audience tends to be highly international.
Best geographic targeting:
- Europe-wide healthcare and medical device audience
- Strong representation from national renal societies and academic hospitals
- Global pharma and medtech companies with EMEA and international business teams
- Hospitals, dialysis chains, and research centers with cross-border clinical programs
3) Audience reach
Reach type: Global, with strong European concentration
ERA Congress is best classified as an international scientific and clinical congress. It has strong European gravity because the association and much of the attendee base come from Europe, but the event is relevant to global kidney care and cross-border medical innovation. For list buyers, this means the event can support both Europe-specific outreach and broader international healthcare prospecting.
4) Sample buyer company names + websites
Below is a sample buyer table with companies that are relevant to kidney care, dialysis, hospital treatment, diagnostics, clinical research, pharmaceutical therapy, and medical technology. These are the kinds of organizations that can be useful for attendee or buyer list monetization, depending on your client’s product.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Baxter | baxter.com | Global Product Manager, Renal Care; Medical Affairs Director | Strong renal and dialysis relevance; a natural buyer for kidney-care-focused event audiences. |
| 2 | Fresenius Medical Care | freseniusmedicalcare.com | Director, Dialysis Operations; Regional Business Development Manager | One of the most direct renal and dialysis market fits for this congress. |
| 3 | DaVita | davita.com | VP, Clinical Operations; Procurement Manager; Clinical Innovation Lead | Dialysis network buyer with strong interest in kidney care products and services. |
| 4 | Roche | roche.com | Medical Affairs Manager; Clinical Research Manager | Large pharma and diagnostics footprint; relevant for renal, immunology, and testing solutions. |
| 5 | Abbott | abbott.com | Regional Marketing Manager, Diagnostics; Product Specialist | Useful for diagnostic, monitoring, and hospital technology buyer profiles. |
| 6 | Siemens Healthineers | siemens-healthineers.com | Global Marketing Manager; Hospital Solutions Director | Hospitals and diagnostic workflows make this a strong buyer match. |
| 7 | Boston Scientific | bostonscientific.com | Clinical Affairs Manager; Market Development Manager | Relevant for interventional and medical technology tied to chronic disease care. |
| 8 | B. Braun | bbraun.com | Renal Therapy Specialist; Product Manager | Direct connection to hospital consumables, infusion, and clinical care infrastructure. |
| 9 | Medtronic | medtronic.com | Senior Product Manager; Clinical Program Manager | Medical technology buyer with strong hospital and clinical engagement value. |
| 10 | Thermo Fisher Scientific | thermofisher.com | Business Development Manager; Laboratory Solutions Lead | Good fit for diagnostics, biomarker research, and clinical laboratory products. |
| 11 | Sanofi | sanofi.com | Medical Affairs Director; Brand Manager | Relevant for chronic disease, immunology, and hospital-facing therapeutic strategy. |
| 12 | AstraZeneca | astrazeneca.com | Global Medical Science Liaison; Clinical Development Director | Strong scientific audience match for renal, cardio-renal, and chronic disease pathways. |
| 13 | Amgen | amgen.com | Medical Affairs Lead; Market Access Manager | Useful for specialty therapy and clinical decision-maker outreach. |
| 14 | GSK | gsk.com | Scientific Engagement Manager; Healthcare Partnerships Lead | Strong healthcare and scientific congress fit for specialist engagement. |
| 15 | Philips | philips.com | Hospital Sales Director; Clinical Solutions Manager | Good for patient monitoring, hospital workflow, and clinical technology positioning. |
| 16 | Siemens | siemens.com | Healthcare Segment Manager; Strategic Account Director | Hospital and diagnostics decision-makers are highly relevant to this audience. |
| 17 | Labcorp | labcorp.com | Clinical Sales Director; Laboratory Partnerships Manager | Excellent fit for diagnostic testing, biomarkers, and clinical research services. |
| 18 | Quest Diagnostics | questdiagnostics.com | Business Development Director; Medical Client Executive | Strong match for hospital and physician-led diagnostic demand. |
| 19 | UCB | ucb.com | Medical Affairs Manager; Market Access Lead | Relevant for specialist therapy and scientific relationship building. |
| 20 | Otsuka | otsuka.co.jp | Country Manager; Medical Science Liaison | Useful for advanced therapeutic and medical conference engagement. |
Top 5 initial buyer targets: Baxter, Fresenius Medical Care, DaVita, Roche, and Siemens Healthineers.
5) Job profiles, industries & event type
This congress is heavily shaped by medical, clinical, scientific, and commercial healthcare decision-makers. If you are building attendee or buyer lists, the best job titles are usually a mix of clinical authority, scientific authority, and buying authority.
Best job profiles to target:
- Nephrologist
- Head of Renal Medicine
- Director of Nephrology
- Medical Affairs Director
- Clinical Research Director
- Clinical Trial Manager
- Dialysis Operations Director
- Hospital Procurement Manager
- Product Manager, Renal Care
- Market Access Manager
- Healthcare Partnerships Lead
- Scientific Liaison / Medical Science Liaison
- Transplant Program Manager
- Renal Nurse Educator
- Diagnostics Business Development Manager
- Hospital Solutions Manager
Best industries to use for targeting:
- Hospital & Health Care
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Research
- Higher Education
- Philanthropy
- Information Services
- Management Consulting
- Medical Practice
- Health, Wellness & Fitness
- Government Administration
Best event type classification: Medical congress, scientific conference, clinical education forum, healthcare exhibition, and specialist networking platform.
Best industry mapping from your list:
- Hospital & Health Care
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Research
- Medical Practice
- Health, Wellness & Fitness
- Higher Education
- Information Services
- Government Administration
- Nonprofit Organization Management
6) Estimated attendance / expected footfall
For a major renal congress, attendance is generally expected in the several-thousand range, often with a strong mix of delegates, speakers, exhibitors, and scientific participants. Since the exact 2026 count depends on official registration trends, the safest estimate should be confirmed from the congress organizer.
Estimated footfall format:
- Clinical delegates: doctors, nurses, researchers, fellows
- Exhibitors and sponsors: medtech, pharma, diagnostics, lab service providers
- Academic attendees: universities, training hospitals, student researchers
- Support staff: organizers, media, association teams, logistics and operations
From a list-seller perspective, the total number matters less than attendee quality. This event has very strong professional density, which means a smaller list can still be highly valuable if it contains the right decision-makers.
7) Key focus areas & buyer engagement
The congress will typically focus on the latest developments in kidney disease prevention, diagnosis, treatment, and long-term management. The buyer engagement value is strongest where the event overlaps with clinical adoption, treatment workflow, lab testing, patient monitoring, and therapeutic innovation.
Key focus areas:
- Chronic kidney disease management
- Dialysis and renal replacement therapy
- Kidney transplantation and post-transplant care
- Acute kidney injury
- Cardio-renal and metabolic complications
- Clinical trials and translational research
- Laboratory diagnostics and biomarker science
- Patient monitoring and digital healthcare tools
- Renal nutrition and multidisciplinary care
- Hospital treatment pathways and healthcare delivery
Buyer engagement angles:
- Clinical education sessions for specialist learning
- Exhibition booths for product demonstrations
- Satellite symposia for pharma and medtech visibility
- Networking with hospital and university decision-makers
- Scientific poster sessions for research relationship building
- Partnership opportunities with renal societies and institutions
If your client sells to hospitals, labs, doctors, dialysis providers, or pharma teams, this is a strong event to extract buyer leads from because the audience has clear budget, treatment, procurement, and scientific influence.
8) Client product review note
Yes, I can review and narrow the best buyers for your client, but I need the client’s website first.
The best buyer list depends completely on what your client sells. For example:
- If your client sells medical devices, we should target hospital buyers, clinical procurement, and product managers.
- If your client sells pharma solutions, we should target medical affairs, market access, and clinical development teams.
- If your client sells diagnostics or lab services, we should target laboratory directors, clinical research managers, and hospital pathology teams.
- If your client sells software, data, or digital health tools, we should target hospital innovation leaders, research teams, and care pathway managers.
Please share the client website, and I can then identify the best buyers, best titles, and best industry filters for this specific congress.
9) Suggested industry mapping based on your industry list
For ERA Congress 2026, the most relevant industry filters from your list are:
- Hospital & Health Care
- Pharmaceuticals
- Medical Devices
- Biotechnology
- Research
- Medical Practice
- Higher Education
- Health, Wellness & Fitness
- Government Administration
- Nonprofit Organization Management
- Information Services
- Management Consulting
Final recommendation
ERA Congress 2026 is a strong event for buyer-list sales if your client serves healthcare, nephrology, dialysis, diagnostics, pharmaceuticals, or medical technology. It is especially valuable because the audience is professionally dense, internationally relevant, and centered around a highly specialized medical field with real commercial buying potential.
Best buyer segments to collect:
- Hospital and renal department decision-makers
- Dialysis providers and network operators
- Medical affairs and clinical research teams
- Pharma and biotech commercial teams
- Medical device and diagnostics companies
- Academic and research institutions
Quality rating for B2B attendee-list sales: 9/10
This is a highly relevant congress for specialist healthcare targeting. The only thing that limits list value is that not every attendee is a direct buyer, so the best results come from filtering toward senior clinical, procurement, commercial, and research decision-makers.
Data sheet
| Event Name | 63rd ERA Congress 2026 |
| Event Date | 3 June 2026 β 6 June 2026 |
| Event Status | Completed |
| Venue | SEC β Scottish Event Campus |
| City | Glasgow |
| State / Region | Scotland |
| Country | United Kingdom |
| Organizer | European Renal Association (ERA) |
| Official Event Website | era-online.org |
| Event Type | International scientific and clinical congress focused on nephrology, renal medicine, dialysis, transplantation, chronic kidney disease management, hospital care, clinical research, medical devices, pharmaceuticals, diagnostics, and professional education |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global primary reach, with strong European concentration |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Current-year total attendance not publicly confirmed; event scale and audience profile supported by official ERA congress positioning and host venue listing |
| Main Purpose of Event | To convene nephrology and kidney-care stakeholders for scientific exchange, clinical education, research dissemination, industry visibility, treatment innovation, and institutional networking across renal care delivery and procurement ecosystems |
The 63rd ERA Congress 2026 is the annual congress of the European Renal Association, centered on nephrology, renal replacement therapy, transplantation, chronic kidney disease, diagnostics, therapeutics, and translational clinical research. The event format indicates a specialist medical congress rather than a consumer exhibition, making it relevant for institutional healthcare buyers, senior clinicians, academic investigators, supplier-side business development teams, and healthcare organizations evaluating treatment pathways, devices, medicines, service models, and research collaboration.
From a market-intelligence perspective, this congress matters because renal medicine is procurement-intensive and multi-stakeholder: hospitals, dialysis networks, universities, transplant programs, pharma companies, medtech firms, lab organizations, and research institutions all intersect here. The event is especially useful for identifying decision-makers involved in clinical adoption, KOL influence, partnership development, scientific visibility, and long-cycle B2B healthcare sales into hospitals, specialty care providers, and research-led institutions.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Nephrologists and renal specialists | University hospitals, renal clinics, specialist kidney centers | Clinical influence on treatment protocols, product selection, and evaluation committees | High relevance for pharmaceuticals, dialysis devices, CKD diagnostics, and care-pathway solutions |
| Hospital procurement and sourcing teams | NHS trusts, academic medical centers, public and private hospital groups | Commercial authority over tenders, contracts, supplier onboarding, and purchasing frameworks | Critical for medtech, consumables, diagnostics, software, and service vendors |
| Dialysis center operators and renal care providers | Dialysis networks, renal service providers, outpatient kidney care operators | Operational and budget influence over equipment, disposables, staffing tools, and workflow systems | High-value buyers for recurring supplies and long-term service contracts |
| Transplant program leaders and surgeons | Transplant centers, tertiary hospitals, surgical research units | Clinical and strategic input into transplant technologies, immunology, and care management tools | Important for transplant-adjacent pharma, diagnostics, monitoring, and care coordination solutions |
| Clinical researchers and trial investigators | Universities, research institutes, teaching hospitals, CRO-linked programs | Influence on trial participation, research partnerships, and evidence generation | Relevant for biotech, pharma, biomarkers, AI research tools, and data platforms |
| Laboratory and diagnostic leaders | Clinical labs, pathology departments, biomarker testing groups | Selection of assay platforms, test menus, and sample workflow technologies | Strong relevance for diagnostics, reagents, informatics, and sample logistics providers |
| Pharmaceutical medical and market access teams | Renal, immunology, and specialty pharma companies | Influence on partnerships, scientific engagement, and commercial strategy | Useful for alliance-building, co-marketing, KOL engagement, and evidence programs |
| Medical device and digital health decision-makers | Dialysis device makers, remote monitoring providers, renal software firms | Partnership, sourcing, integration, and distribution influence | Relevant for channel partnerships, integration, and enterprise deployments |
| Academic institutions and educators | Medical schools, teaching hospitals, research departments | Influence on education tools, fellowships, and collaborative research priorities | Useful for education technology, training, grant support, and research collaboration |
| Healthcare associations and policy stakeholders | Renal societies, patient organizations, public health bodies | Influence on guidelines, awareness, and multi-center networks | Valuable for ecosystem partnerships and market visibility rather than direct procurement |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Glasgow | Local clinicians, hospitals, universities, NHS-linked stakeholders | Medium | Host-city attendance likely includes local academic and hospital communities |
| Scotland | Regional NHS boards, Scottish universities, renal units, research centers | Medium | Strong relevance for renal and transplant programs across Scotland |
| United Kingdom | NHS trusts, universities, kidney research centers, private hospital groups, dialysis providers | High | UK national draw is likely because of event location and specialty relevance |
| Western and Northern Europe | Major nephrology centers from France, Germany, Italy, Spain, Netherlands, Belgium, Nordics, Ireland | Very High | ERA is Europe-centered, so continental attendance is a core feature |
| Broader Europe | Clinicians and researchers from Central, Eastern, and Southern Europe | High | Likely strong scientific and educational participation |
| International / Global | Academic KOLs, global pharma, medtech, multinational renal care stakeholders | High | International medical congress format supports non-European participation, especially from global industry and leading clinical centers |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The congress is organized by a pan-European medical association with international scientific relevance, attracting clinicians, researchers, and healthcare companies across multiple countries. |
| National and European concentration | Secondary description | Although globally relevant, the densest buyer and KOL concentration is expected from the United Kingdom and wider Europe. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| NHS Greater Glasgow and Clyde | Hospital system / public healthcare buyer | Major host-city healthcare organization with renal and hospital procurement relevance | nhsggc.scot | Procurement Manager, Clinical Director Renal Medicine, Head of Pathology, Digital Health Lead | Strong Market Fit, Attendance Not Confirmed |
| NHS Blood and Transplant | Transplant and organ services organization | Direct relevance to kidney transplantation, donor pathways, and clinical collaboration | nhsbt.nhs.uk | Medical Director, Transplant Program Lead, Procurement Lead, Partnership Director | Strong Market Fit, Attendance Not Confirmed |
| University of Glasgow | Academic and clinical research institution | Host-city academic center with medical research and nephrology collaboration relevance | gla.ac.uk | Professor of Nephrology, Research Director, Clinical Trials Lead, Department Administrator | Strong Market Fit, Attendance Not Confirmed |
| NHS Lothian | Hospital system / public healthcare buyer | Large Scottish health board with renal, transplant, and procurement relevance | nhslothian.scot | Procurement Lead, Renal Service Manager, Director of Operations, Consultant Nephrologist | Strong Market Fit, Attendance Not Confirmed |
| Guy's and St Thomas' NHS Foundation Trust | Teaching hospital / specialist renal buyer | Well-known UK kidney and transplant care institution with strong congress relevance | gstt.nhs.uk | Head of Procurement, Renal Clinical Director, Transplant Lead, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| King's College Hospital NHS Foundation Trust | Teaching hospital / renal and transplant stakeholder | Relevant for tertiary nephrology, transplant care, and specialty procurement | kch.nhs.uk | Category Manager, Consultant Nephrologist, Director of Nursing Renal Services, CIO | Strong Market Fit, Attendance Not Confirmed |
| Imperial College Healthcare NHS Trust | Academic health system | Relevant for nephrology research, tertiary care, digital health, and procurement pathways | imperial.nhs.uk | Clinical Director, Strategic Sourcing Lead, Research Operations Manager, IT Director | Strong Market Fit, Attendance Not Confirmed |
| DaVita International | Dialysis provider / operator-side buyer | Direct relevance to dialysis technologies, consumables, and care-delivery partnerships | davita.com | Operations Director, Procurement Director, Medical Affairs Leader, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Fresenius Medical Care | Dialysis provider / integrated renal care operator | Important renal-care organization with procurement, technology, and partnership relevance | freseniusmedicalcare.com | Regional Procurement Head, Clinical Operations Leader, BD Director, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| University College London Hospitals NHS Foundation Trust | Teaching hospital / clinical research buyer | Major UK academic hospital with nephrology and clinical trial relevance | uclh.nhs.uk | Clinical Research Director, Procurement Manager, Department Head Nephrology, Data Lead | Strong Market Fit, Attendance Not Confirmed |
| Oxford University Hospitals NHS Foundation Trust | Academic hospital / transplant and research buyer | High relevance for renal medicine, transplantation, and university-linked research | ouh.nhs.uk | Transplant Program Manager, Procurement Lead, Consultant Nephrologist, Research Manager | Strong Market Fit, Attendance Not Confirmed |
| European Kidney Patients' Federation | Association / policy stakeholder | Relevant to patient outcomes, advocacy partnerships, and policy-linked engagement | ekpf.eu | Secretary General, Program Director, Partnerships Manager, Policy Lead | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Clinical Director, Renal Medicine | Clinical Services | Director | Direct influence on product evaluation, adoption, and treatment standards |
| 2 | Consultant Nephrologist | Medical / Clinical | Manager to Director | Key opinion leader and evaluator of therapies, diagnostics, and care technologies |
| 3 | Procurement Manager | Procurement | Manager | Controls sourcing workflows, supplier selection, and hospital purchasing processes |
| 4 | Category Manager, Medical Devices / Diagnostics | Procurement / Supply Chain | Manager | Important for tenders involving renal devices, monitors, consumables, and lab systems |
| 5 | Director of Procurement | Procurement | Director | High-level sponsor for strategic contracts and enterprise supplier relationships |
| 6 | Transplant Program Lead | Clinical Operations | Director | Relevant for transplant-related technologies, drug support, and pathway management tools |
| 7 | Research Director / Principal Investigator | Research | Director / VP | Critical for trial partnerships, grants, and scientific collaborations |
| 8 | Dialysis Operations Director | Operations | Director | Decision-maker for dialysis workflows, equipment usage, and service quality |
| 9 | Head of Laboratory / Diagnostics | Laboratory Services | Director | Relevant for testing platforms, biomarker panels, and renal diagnostics procurement |
| 10 | Medical Affairs Director | Medical Affairs | Director | Useful for pharmaceutical and device-side scientific partnerships and congress activity |
| 11 | Digital Health / CIO / Health IT Director | Information Technology | Director / C-Level | Relevant where renal pathways involve software, data integration, remote monitoring, or AI support |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer base for renal treatment, procurement, and clinical operations | Hospitals, renal clinics, transplant centers |
| 2 | Medical Devices | Highly relevant to dialysis systems, monitoring, access devices, and care equipment | Device buyers, integration partners, evaluation teams |
| 3 | Pharmaceuticals | Renal therapeutics, immunology, CKD treatment, and congress sponsorship activity | Medical affairs, KOL strategy, partnership outreach |
| 4 | Biotechnology | Biomarkers, translational medicine, and pipeline-stage renal innovations | Trial partnerships and scientific collaboration |
| 5 | Research | Academic and clinical research institutions are central to congress participation | University outreach, investigator engagement |
| 6 | Higher Education | Medical schools and teaching hospitals drive education and speaker participation | Faculty, department heads, research administration |
| 7 | Government Administration | Public health systems and NHS-linked bodies influence procurement and policy | Public sector healthcare contracts and frameworks |
| 8 | Information Technology & Services | Relevant for digital renal care, EHR integration, analytics, and remote monitoring | Hospital IT, connected devices, data platforms |
| 9 | Computer Software | Clinical workflow, registry, analytics, and patient management tools fit the congress audience | Clinical software buyers and innovation leads |
| 10 | Health, Wellness & Fitness | Relevant where preventive kidney health, patient support, and lifestyle management tools are involved | Patient engagement and care support programs |
| 11 | Nonprofit Organization Management | Associations and patient organizations participate in policy and awareness activities | Partnerships, advocacy, ecosystem visibility |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not Publicly Confirmed | Organizer materials reviewed did not provide a confirmed final total | Medical congresses of this profile are typically large, but no figure is stated here without confirmation |
| Exhibitor count | Not publicly confirmed | Not Publicly Confirmed | No verified current-year exhibitor total identified in reviewed materials | Industry participation is likely substantial, but count is unverified |
| Buyer count | Not publicly confirmed | Not Publicly Confirmed | No official attendee-segmentation total disclosed | Clinical buyers are present, but the congress is not positioned as a pure hosted-buyer event |
| Speaker count | Not publicly confirmed | Not Publicly Confirmed | Program volume suggests a sizeable faculty base | Exact number should be taken only from the final official program |
| Sponsor count | Not publicly confirmed | Not Publicly Confirmed | No consolidated verified sponsor total identified | Pharma and medtech sponsorship is common in this congress category |
| Historical attendance | Large international congress format | Historical / prior-format evidence | ERA annual congress positioning and long-running association format | Useful for lead-priority scoring, but not a substitute for an official current-year count |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Dialysis and renal replacement therapy | Better equipment, disposables, treatment quality, and workflow efficiency | Clinical demos, product evaluation meetings, operations discussions | Dialysis systems, consumables, service contracts, digital monitoring |
| Chronic kidney disease management | Earlier diagnosis, better monitoring, outpatient care support | Value-based care conversations, pathway redesign, evidence-led selling | Diagnostics, patient management software, disease monitoring tools |
| Transplantation | Improved patient outcomes, donor-recipient coordination, long-term monitoring | Meetings with transplant programs, clinical leaders, and policy stakeholders | Immunology products, monitoring diagnostics, data systems, patient support services |
| Clinical research and trials | Investigator sites, translational science partners, evidence generation | Investigator networking, abstract-led prospecting, study collaboration outreach | Research tools, CRO support, data capture, biostatistics, biomarker platforms |
| Diagnostics and laboratory medicine | Reliable testing, biomarker adoption, lab workflow optimization | Lab leader meetings and procurement pathway mapping | Assays, analyzers, sample management, informatics |
| Hospital procurement | Cost control, clinical quality, regulatory fit, supplier continuity | Tender preparation, framework discussions, local distributor partnerships | Contract-ready medtech, diagnostics, pharma support, managed services |
| Digital transformation in renal care | Remote monitoring, data integration, patient tracking, analytics | IT-clinical joint discussions and pilot program outreach | Software, interoperability tools, cloud platforms, AI support systems |
| Education and guideline dissemination | Continuous medical education and evidence-based practice updates | Faculty engagement, branded education, institutional training support | Education platforms, simulation, learning content, grants support |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The congress is highly relevant for specialized healthcare sellers targeting nephrology, dialysis, diagnostics, transplant, and research ecosystems. |
| Decision-maker availability | High | Senior clinicians, department leaders, medical affairs teams, and procurement-linked stakeholders are likely present, although not always in explicit hosted-buyer formats. |
| Data collection potential | Medium | Medical congresses can provide strong networking value, but attendee data is often more restricted than open commercial expos. |
| Apollo targeting potential | High | Hospital systems, universities, medtech, pharma, and research organizations map well to Apollo industry, title, geography, and size filters. |
| Geographic targeting potential | Very High | Strong clustering exists in the UK and Europe, with additional global KOL and supplier participation. |
| Best outreach approach | High | Use evidence-led outreach focused on renal outcomes, efficiency, clinical validation, and institutional value rather than generic sales messaging. |
| Overall lead quality | High | Excellent event for specialty healthcare targeting, especially when the client sells to hospitals, researchers, renal clinics, or medtech/pharma partners. |
| Best use case | High | Best suited for KOL mapping, institutional prospecting, clinical partnership building, exhibitor targeting, and account-based outreach to renal-care stakeholders. |
| Limitations / risks | Medium | Public attendee transparency may be limited; many valuable contacts are scientific rather than direct procurement contacts, so title qualification is important. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Government Administration; Information Technology & Services; Computer Software; Nonprofit Organization Management | Covers provider-side, research-side, and supplier-side organizations connected to renal care |
| Departments | Procurement, Operations, Medical, Research, Information Technology, Business Development, Partnerships, Supply Chain | Captures both direct buyers and strong clinical influencers |
| Seniority | C-Level, VP, Director, Head, Manager | Prioritizes budget holders, clinical leaders, and implementation owners |
| Job titles | Clinical Director, Consultant Nephrologist, Director of Procurement, Procurement Manager, Category Manager, Transplant Program Lead, Dialysis Operations Director, Medical Affairs Director, Head of Laboratory, Research Director, CIO, Health IT Director | Best-fit roles for medical buying, evaluation, and partnerships |
| Geography | United Kingdom, Scotland, England, Ireland, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Nordics | Focus on core ERA catchment markets and host-region relevance |
| Employee size | 201β500; 501β1,000; 1,001β5,000; 5,001β10,000; 10,001+ | Filters for hospital systems, universities, large medtech, and pharma organizations |
| Keywords | nephrology, renal, kidney, dialysis, transplant, CKD, hemodialysis, peritoneal dialysis, biomarker, hospital procurement, renal research | Improves precision for specialty renal accounts and contacts |
| Technologies, if relevant | EHR integration, remote monitoring, clinical analytics, diagnostic platforms, laboratory information systems | Useful for digital-health, software, and connected-device sellers |
| Revenue range | Mid-market to enterprise healthcare organizations | Supports prioritization of larger institutional buyers with multi-site purchasing capacity |
| Company type | Public hospital systems, academic medical centers, specialty clinics, research institutions, public agencies, enterprise medtech and pharma | Aligns event audience with likely enterprise outreach targets |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| European Renal Association (ERA) | Official organizer website | Organizer identity, annual congress positioning, nephrology focus, association ownership | High |
| Scottish Event Campus (SEC) | Official venue website | Venue name and Glasgow location | High |
| NHS Greater Glasgow and Clyde | Official healthcare organization website | Host-city buyer-side institutional relevance for renal and hospital procurement prospecting | High for organization existence; not attendance confirmation |
| NHS Blood and Transplant | Official government-linked healthcare organization website | Transplant ecosystem relevance and buyer-side role | High for organization existence; not attendance confirmation |
| University of Glasgow | Official university website | Host-city academic research relevance to nephrology and congress networking | High for organization existence; not attendance confirmation |
| User-provided known event details | Input data | Start date, end date, venue, city, region, and country | Provisional, consistent with organizer/venue context |
π― Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 63rd ERA Congress 2026 β the bestβfit companies to target, the exact decisionβmaker job titles, and the industry filters that fit what you sell.